InsiderFlow

Robert E Landry

REGN

Robert E Landry serves as director at Regeneron Pharmaceuticals, Inc. (REGN). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

17 trades

$9.29M

Net Position

Net Seller

$9.29M

Companies Traded

2

CYTK, REGN

Active Period

Aug 2021 – Sep 2026

17 total trades

Most Recent

Sell CYTK

Sep 15, 2026 · $72.1K

Robert E Landry's Insider Trading at Regeneron Pharmaceuticals, Inc. (REGN)

Buys

0 · $0.00

Sells

15 · $9.15M

Total Shares Bought

0

Total Shares Sold

12,702

REGN Price Chart
Loading chart...
DateTypeValue
Aug 25, 2023 Sell$188.2K
Mar 29, 2023 Sell$979.6K
Feb 7, 2023 Sell$1.16M
Dec 2, 2022 Sell$461.6K
Nov 2, 2022 Sell$365.4K
Oct 18, 2022 Sell$264.7K
Apr 11, 2022 Sell$1.61M
Apr 1, 2022 Sell$219.9K
Mar 30, 2022 Sell$1.85M
Mar 23, 2022 Sell$207.9K
Mar 18, 2022 Sell$260.0K
Dec 14, 2021 Sell$76.8K
Dec 10, 2021 Sell$520.5K
Nov 18, 2021 Sell$439.3K
Aug 10, 2021 Sell$553.5K

Robert E Landry's Insider Trading at Cytokinetics, Incorporated (CYTK)

Buys

0 · $0.00

Sells

2 · $146.8K

Total Shares Bought

0

Total Shares Sold

2,000

CYTK Price Chart
Loading chart...
DateTypeValue
Sep 15, 2026 Sell$72.1K
Sep 11, 2026 Sell$74.7K